Tumor Immune Microenvironment

The tumor immune microenvironment (TIME) is composed of hetereogenous immune cells that have infiltrated the tumor, and is a central target of cancer immunotherapies. Characterization of the TIME is key to predicting response and development of immunotherapy. Discover the latest research here.

September 16, 2021
Open Access

Construction of a solid Cox model for AML patients based on multiomics bioinformatic analysis

BioRxiv : the Preprint Server for Biology
Lei GaoY. Su
September 16, 2021

Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer.

Cancer Immunology, Immunotherapy : CII
Tomotaka UgaiShuji Ogino
September 16, 2021
Open Access

HCG18 Participates in Vascular Invasion of Hepatocellular Carcinoma by Regulating Macrophages and Tumor Stem Cells.

Frontiers in Cell and Developmental Biology
Liwei ZhangZhiju Wang
September 16, 2021
Open Access

N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target.

Frontiers in Immunology
Chao QuanXiongbing Zu
September 16, 2021

circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma.

Journal of Experimental & Clinical Cancer Research : CR
Ya-Ping XuChuan-Yong Guo
September 16, 2021

Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy.

Current Treatment Options in Oncology
Giulia MazzaschiFrancesco Facchinetti
September 16, 2021

Enzyme-responsive micellar JQ1 induces enhanced BET protein inhibition and immunotherapy of malignant tumors.

Biomaterials Science
Zhenqi ZhangChao Deng
September 16, 2021

Cell-to-cell interaction analysis of prognostic ligand-receptor pairs in human pancreatic ductal adenocarcinoma.

Biochemistry and Biophysics Reports
Sayaka R SuzukiHaruka Ozaki
September 16, 2021

A review of the endocrine resistance in hormone-positive breast cancer.

American Journal of Cancer Research
Tsai-Ju Chien
September 16, 2021

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer.

Research in Pharmaceutical Sciences
Ilnaz Rahimmanesh, Hossein Khanahmad
September 16, 2021

PLK1 Inhibition Induces Immunogenic Cell Death and Enhances Immunity against NSCLC.

International Journal of Medical Sciences
Jie ZhouJing Cheng

Sign up to follow this feed and discover related papers.

Related Feeds

Antibody Engineering

Antibody engineering technologies are constantly advancing to improve the clinical effectiveness of monoclonal and bispecific antibodies. Discover the latest research on Antibody Engineering here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Biophysics of Adhesion

Alterations in cell adhesion can disrupt important cellular processes and lead to a variety of diseases, including cancer and arthritis. It is also essential for infectious organisms, such as bacteria or viruses, to cause diseases. Understanding the biophysics of cell adhesion can help understand these diseases. Discover the latest research on the biophysics of adhesion here.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

© 2021 Meta ULC. All rights reserved